Development of biopharmaceutical finished dosage forms
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Presentation
- By: CHERIAN, Mathew (Hospira Inc, Pharmaceutical Development, Lake forest, United States of America)
Transforming Active Pharmaceutical Ingredient (API) to finished dosage form encompasses the areas of formulation development, analytical method development, process development and scale up, and technology transfer to one or more manufacturing sites. The presentation will address issues related to development of sterile finished dosage forms of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.